InvestorsHub Logo
Followers 1
Posts 15
Boards Moderated 0
Alias Born 05/28/2013

Re: None

Monday, 05/04/2015 4:37:19 PM

Monday, May 04, 2015 4:37:19 PM

Post# of 2028
FDA approval within reach

The threshold for approval of CR845 is probably a lot lower than most believe. Because of the tremendous safety and addiction profile of the drug, it could have the pain reduction efficacy of gabapentin or lyrica and easily get FDA approval. Previous studies have blown those comparisons out of the water, so a decent phase III trial will nearly guarantee this thing going to market.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CARA News